canertinib dihydrochloride has been researched along with Leukemia L 1210 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hook, KE; Leopold, WR; Przybranowski, SA | 1 |
1 other study(ies) available for canertinib dihydrochloride and Leukemia L 1210
| Article | Year |
|---|---|
Cellular transport of CI-980.
Topics: Animals; Antineoplastic Agents; Biological Transport; Carbamates; Carrier Proteins; Cattle; CHO Cells; Cricetinae; Dipyridamole; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Humans; Leukemia L1210; Platelet Aggregation Inhibitors; Pyrazines; Pyridines; Stereoisomerism | 1996 |